Advanced Solid Tumors: PM534 Treatment Study

We are testing a new drug called PM534 in patients with advanced solid tumors. The goal is to learn more about its safety and how it may work in treating this condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Hm Nou Delfos
START Barcelona
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
START Madrid-HM CIOCC
Chamartín, Spain
Hospital Universitario Fundacion Jimenez Diaz
START Madrid-FJD
Madrid, Spain
Sponsor: Pharma Mar S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.